Brief: Tuhura Biosciences Releases Kintara CVR After Safety Milestone
15/12/2025 13:59
Dec 15 (Reuters) - TuHURA Biosciences Inc HURA.O: TUHURA BIOSCIENCES ANNOUNCES ITS RELEASE OF KINTARA'S CONTINGENT VALUE RIGHT (CVR) AS KINTARA'S REM-001 MEETS PRIMARY SAFETY ENDPOINT ACHIEVING CONTRACTUAL MILESTONE Source text: ID:nPn7GHWhna Further company coverage: HURA.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on TuHURA Biosciences
See all newsBrief: Tuhura Biosciences Receives Key U.S. Patent For Its Groundbreaking Delta Opioid Receptor Antibody Drug Conjugate Technology
TuHURA Biosciences Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Tuhura Biosciences Reports Second Quarter 2026 Financial Results And Provides A Corporate Update
TuHURA Biosciences Inc expected to post a loss of 14 cents a share - Earnings Preview
Brief: Tuhura Biosciences Inc Enters At The Market Offering Agreement With H.C. Wainwright & Co.